Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

232
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
232
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

384
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
384
Analgesia and Pain Management01:25

Analgesia and Pain Management

525
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
525
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Live-birth rates after four consecutive failed IVF cycles within one year: A retrospective cohort study of patients aged 35 years and older.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery.

JAMA network open·2026
Same author

Implementing occupational therapy quality indicators in a large healthcare system: lessons from a 5-year performance monitoring study.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026
Same author

Long-Term Outcomes of Combined Phacoemulsification and Non-Penetrating Deep Sclerectomy versus Standalone Non-Penetrating Deep Sclerectomy.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Initiation of GLP-1 Receptor Agonists Treatment after Bariatric Metabolic Surgery and Major Adverse Cardiac Events.

Obesity facts·2026
Same author

The effect of nurse care management on multimorbid patients' hospital utilization: a comparative-controlled trial and an exploratory cohort study.

Nature communications·2026

Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.0K

Fentanyl Initiation Rate Following the Requirement for Specialist Approval.

Oren Miron1,2, Yael Wolff-Sagy3, Mark Levin4

  • 1Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel. Orenmir@post.bgu.ac.il.

Journal of General Internal Medicine
|November 4, 2024
PubMed
Summary

Requiring specialist approval significantly reduced fentanyl initiation for non-oncological pain by 81%. This policy also lowered overall opioid use, demonstrating its effectiveness in controlling potent opioid prescriptions.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.4K
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

742

Related Experiment Videos

Last Updated: Jun 8, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.0K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.4K
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

742

Area of Science:

  • Pain Management
  • Public Health Policy
  • Pharmacovigilance

Background:

  • Unwarranted fentanyl use poses significant risks of addiction and overdose.
  • Healthcare systems seek strategies to mitigate risks associated with potent opioid analgesics.
  • Fentanyl is a potent synthetic opioid increasingly used for pain management.

Purpose of the Study:

  • To evaluate the impact of mandatory specialist approval on initiating fentanyl for non-oncological pain.
  • To assess changes in overall opioid dispensation following the policy implementation.

Main Methods:

  • Retrospective cohort study utilizing observational data from 4.4 million members of Clalit Health Services (July 2021-July 2023).
  • Assessed fentanyl initiation rates before and after policy implementation (July 2022) and its expansion for continued use.
  • Conducted subgroup analysis by age and compared total opioid dispensation to predicted rates.

Main Results:

  • Fentanyl initiation decreased by 81% post-policy implementation (711 to 135 per million capita).
  • The reduction in fentanyl initiation was less pronounced in older age groups.
  • Total opioid dispensation (MME) was 7% lower at 6 months and 26% lower at 12 months compared to predictions.

Conclusions:

  • Specialist approval for fentanyl initiation effectively reduced its use in non-oncological pain, particularly in younger patients.
  • The policy also led to a gradual decrease in total opioid dispensations.
  • Mandatory specialist approval for initiating and continuing fentanyl may be a valuable tool for controlling potent opioid use.